Division of Research, Kaiser Permanente Northern California, Oakland (E.P.G., S.S.).
Departments of OB/GYN and Epidemiology, University of Pittsburgh, PA (B.S., J.M.C.).
Circulation. 2021 Mar 9;143(10):974-987. doi: 10.1161/CIRCULATIONAHA.120.047320. Epub 2021 Feb 1.
Gestational diabetes (GD) leads to earlier onset and heightened risk of type 2 diabetes, a strong risk factor for cardiovascular disease (CVD). However, it is unclear whether attaining normoglycemia can ameliorate the excess CVD risk associated with GD history. This study sought to evaluate GD history and glucose tolerance after pregnancy associated with coronary artery calcification (CAC) in women, a manifestation of atherosclerotic CVD and a predictor of CVD clinical events.
Data were obtained from the CARDIA study (Coronary Artery Risk Development in Young Adults), a US multicenter, community-based prospective cohort of young Black (50%) and White adults aged 18 to 30 years at baseline (1985-1986). The sample included 1133 women without diabetes at baseline, who had ≥1 singleton births (n=2066) during follow-up, glucose tolerance testing at baseline and up to 5 times during 25 years (1986-2011), GD status, and CAC measurements obtained from 1 or more follow up examinations at years 15, 20, and 25 (2001-2011). CAC was measured by noncontrast cardiac computed tomography; dichotomized as Any CAC (score>0) or No CAC (score=0). Complementary log-log models for interval-censored data estimated adjusted hazard ratios of CAC and 95% confidence intervals for GD history and subsequent glucose tolerance groups (normoglycemia, prediabetes, or incident diabetes) on average 14.7 years after the last birth adjusted for prepregnancy and follow-up covariates.
Of 1133 women, 139 (12.3%) reported GD and were 47.6 years of age (4.8 SD) at follow-up. CAC was present in 25% (34/139) of women with GD and 15% (149/994) of women with no GD. In comparison with no GD/normoglycemia, adjusted hazard ratios (95% CIs) were 1.54 (1.06-2.24) for no GD/prediabetes and 2.17 (1.30-3.62) for no GD/incident diabetes, and 2.34 (1.34-4.09), 2.13 (1.09-4.17), and 2.02 (0.98-4.19) for GD/normoglycemia, GD/prediabetes, and GD/incident diabetes, respectively (overall =0.003).
Women without previous GD showed a graded increase in the risk of CAC associated with worsening glucose tolerance. Women with a history of GD had a 2-fold higher risk of CAC across all subsequent levels of glucose tolerance. Midlife atherosclerotic CVD risk among women with previous GD is not diminished by attaining normoglycemia.
妊娠糖尿病(GD)会导致 2 型糖尿病的发病更早且风险更高,而 2 型糖尿病是心血管疾病(CVD)的一个强有力的危险因素。然而,尚不清楚是否能使血糖恢复正常以减轻与 GD 病史相关的 CVD 风险增加。本研究旨在评估 GD 病史和产后血糖耐量与女性冠状动脉钙化(CAC)之间的关系,后者是动脉粥样硬化性 CVD 的表现,也是 CVD 临床事件的预测指标。
数据来自 CARDIA 研究(年轻人冠状动脉风险发展),这是一项美国多中心、基于社区的年轻人黑人(50%)和白人成年人的前瞻性队列研究,基线年龄为 18-30 岁(1985-1986 年)。该样本包括基线时无糖尿病的 1133 名女性,在随访期间至少有 1 次单胎妊娠(n=2066),在 25 年期间进行了基线和多达 5 次的葡萄糖耐量测试(1986-2011 年)、GD 状态以及 1 次或多次后续检查(15 年、20 年和 25 年(2001-2011 年))中获得的 CAC 测量值。CAC 通过非对比心脏计算机断层扫描测量;分为有 CAC(评分>0)或无 CAC(评分=0)。平均在最后一次分娩后 14.7 年,对具有 GD 病史和随后的葡萄糖耐量组(血糖正常、糖尿病前期或新发糖尿病)的 CAC 和 95%置信区间进行了间隔截尾数据的互补对数-对数模型估计,调整了妊娠前和随访期间的协变量。
在 1133 名女性中,139 名(12.3%)报告了 GD,在随访时年龄为 47.6 岁(4.8 标准差)。GD 组中有 25%(34/139)的女性存在 CAC,而无 GD 组中有 15%(149/994)的女性存在 CAC。与无 GD/血糖正常相比,无 GD/糖尿病前期的调整后的危险比(95%CI)为 1.54(1.06-2.24),无 GD/新发糖尿病为 2.17(1.30-3.62),GD/血糖正常、GD/糖尿病前期和 GD/新发糖尿病分别为 2.34(1.34-4.09)、2.13(1.09-4.17)和 2.02(0.98-4.19)(总体=0.003)。
无既往 GD 的女性随着血糖耐量恶化,CAC 相关风险呈递增趋势。有 GD 病史的女性无论随后的血糖耐量水平如何,其 CAC 风险均增加 2 倍。患有 GD 的女性在中年时的动脉粥样硬化性 CVD 风险并未因血糖恢复正常而降低。